Nasal and pulmonary drug-delivery device manufacturer Aptar Pharma will present its products at Pharmapack Europe, taking place 13 to 14 February 2013 at the Grande Halle de la Villette in Paris. Aptar Pharma provides systems for the delivery of unpreserved formulations.
The company recently announced that it has increased its production capacities in Eigeltingen, Germany, for the delivery of unpreserved formulations. The expansion will help support the continuous demand for preservative-free ophthalmic and nasal drugs.
Aptar Pharma also announced it has developed a customised dose indicator for Flutiform, a SkyePharma product for the treatment of asthma. The system is a customised version of Aptar Pharma's Landmark dose indicator actuator. The system dictates the remaining doses downwards and provides the patient with a visual colour and numerical reference when it is time to renew the prescription, before the canister becomes empty.